That the loss of functional TRβ led to cancer development suggested that TRs broadly control transcriptional programs to suppress oncogenesis, raising the possibility that TRβ could be targeted for treatment of thyroid cancer. This evidence concerns the gene THRB and thyroid gland carcinoma.